Citadel Advisors’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Citadel Advisors’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,824	Closed	-$42.2K	–	15903
2023 Q4	$42.2K	Buy	2,824 +929	+49%	+$38.6K	﹤0.01%	11963
2023 Q3	$121K	Buy	+1,895	New	+$133K	﹤0.01%	10659
2023 Q1	–	Sell	-1,537	Closed	-$168K	–	16266
2022 Q4	$168K	Sell	1,537 -3,732	-71%	-$558K	﹤0.01%	10425
2022 Q3	$1.12M	Sell	5,269 -13,022	-71%	-$2.63M	﹤0.01%	6742
2022 Q2	$1.99M	Buy	18,291 +14,182	+345%	+$2.43M	﹤0.01%	5554
2022 Q1	$921K	Sell	4,109 -710	-15%	-$147K	﹤0.01%	7901
2021 Q4	$1.11M	Buy	4,819 +1,857	+63%	+$442K	﹤0.01%	7702
2021 Q3	$858K	Buy	+2,962	New	+$872K	﹤0.01%	8529

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's CMAX Position: Q1 2024 in Review

Citadel Advisors sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2024, closing a stake of 2,824 shares — an estimated $42.2K sold.

Citadel Advisors first reported a position in CMAX in Q3 2021 and held it in 8 quarters. The position peaked at $1.99M in Q2 2022. 42 funds tracked by Wall St. Rank hold CMAX as of Q1 2024.

Citadel Advisors reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 2,824 CareMax, Inc. Class A Common Stock shares in Q1 2024, an estimated $42.2K.
Citadel Advisors first reported a position in CareMax, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
Citadel Advisors's CareMax, Inc. Class A Common Stock position peaked at $1.99M in Q2 2022.
42 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.